Transformation from lung adenocarcinoma to pulmonary giant cell carcinoma following targeted therapy: a case report - Top-Institutions - MDSpire

Transformation from lung adenocarcinoma to pulmonary giant cell carcinoma following targeted therapy: a case report

  • By

  • Shicheng Yuan

  • Qun Zhang

  • Yanling Xu

  • Yanfeng Wu

  • Qi Wang

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    our hospital
    our hospital

    Unknown, Unknown

    Key Differentiators

    • Oncology

  • #2

    outside hospital
    outside hospital

    Unknown, Unknown

    Key Differentiators

    • Oncology

  • #3

    The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai
    The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Oncology

  • #4

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei

    Key Differentiators

    • Oncology

  • #5

    Beijing Tongren Hospital
    Beijing Tongren Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

Original Source(s)

Transformation from lung adenocarcinoma to pulmonary giant cell carcinoma following targeted therapy: a case report

  • by Shicheng Yuan, Qun Zhang, Yanling Xu, Yanfeng Wu, Qi Wang

  • July 14, 2026

Related Content

Designing and conducting interventional trials with passive-sensing applications on patient-owned smartphones: challenges and recommendations from the BD4QoL study

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report

Navigating the gut–metabolite–immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors